Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home-administered subcutaneous tezepelumab via accessorized pre-filled syringe vs autoinjector in severe asthma
jRCT2080224731Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, open-label trial of tezepelumab in asthma (2 arms), sponsored by AstraZeneca. Started Jun 2019; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080224731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224731.